31st March 2021
Step 1 − Risk evaluation for Chemical medicines
1st July 2021
Step 1 − Risk evaluation for Biological medicines
26th September 2022
Step 2 − Confirmatory testing for Chemical medicines
1st July 2023
Step 3 − Update marketing authorisations for Biological medicines
1st October 2023
Step 3 − Update marketing authorisations for Chemical medicines
You can check ToxBy.Design methodology for Nitrosamine Impurities Assessment report, which are duly validated and signed by an European Registered Toxicologist expert.
In the event you are performing this exercise for innovative compounds GMP scale up manufacturing, please be noted that ToxBy.Design is duly accredited for the French Research Tax Credit CIR.
Feel free to contact us using the Quotation Request below to receive a quotation for Nitrosamine Impurities Assessment report for your Drug products.